MME and Alzheimer disease: Rofo and colleagues successfully introduced soluble NEP into the brain parenchyma of an AD mouse model using a transferrin receptor antibody conjugate construct and showed that the soluble NEP preferentially degrades Aβ monomer (Rofo et al., 2022).